Key Highlights
- Altria (MO) reached a fresh 52-week peak of $76.17, currently trading at $76.48
- First-quarter earnings per share of $1.32 exceeded analyst forecasts of $1.25; revenue of $4.76B surpassed projections by $180M
- Company projects full-year 2026 EPS between $5.56 and $5.72
- Maintains quarterly dividend at $1.06 per share, yielding approximately 5.5%
- Wall Street consensus stands at “Hold” with a mean price target of $70.78
Shares of MO climbed to a new 52-week peak on Tuesday, briefly reaching $76.17 before closing near $76.48 — a significant jump from the prior session’s close of $72.89. The tobacco giant has delivered impressive gains of 30.45% since the start of the year and posted 32.55% returns over the trailing 12-month period.
This upward momentum follows a robust quarterly earnings performance. The company reported earnings per share of $1.32, exceeding Wall Street’s consensus forecast of $1.25. Total revenue reached $4.76 billion, marking a 5.3% increase from the same period last year and surpassing analyst expectations of $4.58 billion.
Looking ahead to fiscal year 2026, management has established EPS guidance ranging from $5.56 to $5.72. The Street’s current estimate stands at $5.70 for the full year.
Income Investors Remain Attracted
Altria distributed a quarterly dividend of $1.06 on July 10, translating to an annual payout of $4.24 and yielding approximately 5.5%. This marks the 56th consecutive year the company has sustained its dividend payments.
While the payout ratio stands at an elevated 88.7%, the company’s strong income generation continues to appeal to dividend-seeking investors.
Recent insider activity showed two board members reducing their holdings in May. Debra J. Kelly divested 5,790 shares at $72.25, trimming her stake by 7.27%. Ellen R. Strahlman sold 2,000 shares at $72.56, representing a 7.38% decrease in her position. Both sales were properly filed with the SEC.
Institutional ownership accounts for 57.41% of outstanding shares. Multiple asset managers have expanded their positions in recent quarters, including Bernardo Wealth Planning, which boosted its holdings by 4.6% during the second quarter.
Wall Street Remains Cautious
The Street’s consensus recommendation for MO stands at “Hold,” with an average price target of $70.78 — notably below current trading levels.
UBS maintains a Buy recommendation with a $79 price objective. Bank of America revised its projections following supportive regulatory developments affecting the tobacco industry during Q2. BTIG launched coverage in July with a Neutral stance.
Citigroup increased its target from $65 to $70 while maintaining a Neutral rating. Morgan Stanley carries a $71 price objective. Jefferies holds an Underperform view with a $60 target. Across the 12 analysts tracking the stock, five recommend Buy, five suggest Hold, and two advise Sell.
The FDA recently unveiled a proposed regulation mandating foreign tobacco producers to register their manufacturing facilities. Industry observers view this development as favorable for U.S.-based manufacturers such as Altria.
Sales data from Bank of America through late May indicated expansion in oral tobacco products, while traditional cigarette and vaping product sales experienced declines.
The company maintains a market capitalization of $127.82 billion, trades at a price-to-earnings multiple of 16.01, and has a beta coefficient of 0.45. Its 50-day moving average sits at $71.90, while the 200-day moving average stands at $67.95.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
